CVS Group (CVSG) Share Price, News & Analysis

Company Overview

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy. The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct"). The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

Key Stats

• Today's Range: 1,208 to 1,288
• 50-Day Range: 1,196 to 1,337.51
• 52-Week Range: 1,062 to 1,648
• Volume: 436,037 shs
• Average Volume: 879,295 shs
• Market Capitalization: £821.08 million
• P/E Ratio: 17.53
• Dividend Yield: 0.65%
• Price Target: GBX 1,666.67
• Consensus Rating: Moderate Buy

CVS Group Stock Analysis - MarketRank™

CVS Group scored higher than 84% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.1 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

CVS Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 4 buy ratings, 2 hold ratings, and no sell ratings.

Upside Potential

CVS Group has a consensus price target of GBX 1,666.67, representing about 38.0% upside from its current price of GBX 1,208.

Amount of Analyst Coverage

CVS Group has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of CVS Group is 17.53, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.64.

Price to Earnings Ratio vs. Sector

The P/E ratio of CVS Group is 17.53, which means that it is trading at a less expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 44.33.

Price to Earnings Growth Ratio

CVS Group has a PEG Ratio of 1.77. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

CVS Group has a P/B Ratio of 3.33. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for CVSG.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

CVS Group has a dividend yield of 0.65%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

CVS Group does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of CVS Group is 12.34%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.58

News Sentiment

CVS Group has a news sentiment score of 0.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Consumer Discretionary companies.

News Coverage This Week

MarketBeat has tracked 15 news articles for CVS Group this week, compared to 1 article on an average week.

Company Ownership

• Score: 3.5 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

3 insiders have purchased shares of CVS Group in the last three months. Multiple insiders buying is a strong bullish signal.

Net Insider Buying

Over the last three months, insiders have purchased a net £49,566.96 in company stock, which represents 0.0060% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, CVS Group insiders have bought more of their company's stock than they have sold. Specifically, they have bought £49,566.96 in company stock and sold GBX 0 in company stock.

Percentage Held by Insiders

1.48% of the stock of CVS Group is held by insiders.

Percentage Held by Institutions

48.54% of the stock of CVS Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 9/24/2026
• Today: 9/27/2026

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Consumer Discretionary
• Industry: Diversified Consumer Services
• Sub-Industry: N/A
• Current Symbol: LON:CVSG
• CIK: N/A
• Web: www.cvsukltd.co.uk
• Phone: +44-1379-644288
• Fax: N/A
• Employees: 9,100
• Year Founded: N/A

Price Target and Rating

• Average Price Target for CVS Group: GBX 1,666.67
• High Price Target: GBX 2,000
• Low Price Target: GBX 1,400
• Potential Upside/Downside: +38.0%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): GBX 68.90
• Trailing P/E Ratio: 17.53
• Forward P/E Ratio: 12.86
• P/E Growth: 1.77
• Net Income: £20.68 million
• Net Margins: 2.43%
• Pretax Margin: N/A
• Return on Equity: 5.91%
• Return on Assets: 5.03%

Debt

• Debt-to-Equity Ratio: 110.41
• Current Ratio: 1.18
• Quick Ratio: 0.90

Sales & Book Value

• Annual Sales: £712.80 million
• Price / Sales: 1.15
• Cash Flow: GBX 39.82 per share
• Price / Cash Flow: 30.33
• Book Value: GBX 363.16 per share
• Price / Book: 3.33

Miscellaneous

• Outstanding Shares: 67,970,000
• Free Float: N/A
• Market Cap: £821.08 million
• Optionable: Not Optionable
• Beta: 1.07